q Fever Clinical Trial
Official title:
Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island
Emergent and infectious diseases are a public health priority on Reunion Island. Amongst
public health threats, the infection due to Coxiella burnetii (Q fever) seems to have
appeared on Reunion island in 2007 with two hospitalised confirmed cases (one death) and one
probable case with a goat farmer.
According to the investigator, the diffusion of C. burnetti is more ancient and such
diagnosis have been made in the last 30 years with 80 positive serologies identified between
2005 and 2011.
Considering the high epidemic power of this disease, its often silent clinical expression
and its life-threatening condition, the principal investigator wishes to perform a
sero-epidemiological study in order to establish or to reject the risk of emergence of Q
fever in Reunion island.
The study will be performed on pregnant women because Q fever is responsible for particular
complications during pregnancy and because the number of pregnancy followed on Reunion
island is stable from one year to the other. The pregnant women population presenting the
same exposure criteria as the general population, this population will be used to
extrapolate to the general population of the island.
n/a
Observational Model: Ecologic or Community, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03334019 -
Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France
|
||
Active, not recruiting |
NCT01450501 -
Chronic Q-fever in Patients With an Abdominal Aortic Disease (QAAD-study)
|
N/A | |
Recruiting |
NCT01095328 -
A Screening Strategy for Q Fever Among Pregnant Women
|
N/A | |
Completed |
NCT02822807 -
Q Fever and Auto-immunity
|
N/A | |
Completed |
NCT00584454 -
Safety Evaluation of a Q-fever Vaccine, NDBR 105
|
Phase 2 | |
Withdrawn |
NCT02092142 -
Safety and Immunogenicity of Q Fever Vaccine
|
Phase 2 | |
Completed |
NCT01318356 -
The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment
|
Phase 4 |